Table 2a Hazard ratios for multivariate model for prostate cancer death based on Gleason score and PSA, in patients having both variables available
From: Long-term outcome among men with conservatively treated localised prostate cancer
Prostate cancer death | |||
|---|---|---|---|
Variable | Total eligible ( N =1656) | No initial treatment ( N =1176) | Initial hormones ( N =480) |
Gleason score a | |||
⩽5 | 0.67 | 0.63 | 1.50 |
6 | 1b | 1b | 1b |
7 (3+4, 4+3) | 1.77 | 1.88 | 1.13 |
8 (3+5, 4+4, 5+3) | 3.00 | 3.26 | 1.79 |
9 or 10 | 5.96 | 6.77 | 3.56 |
Serum PSA (ng ml−1) | |||
⩽4 | 1b | 1b | 1b |
>4–10 | 1.06 | 0.81 | 1.05 |
>10–25 | 1.42 | 1.60 | 0.65 |
>25–50 | 2.23 | 1.67 | 1.73 |
>50–100 | 2.62 | 1.92 | 1.67 |
